Scynexis (SCYX) Liabilities from Discontinued Operations (2014 - 2015)

Scynexis (SCYX) posted Liabilities from Discontinued Operations of 2099000.0 for Q2 2015, down 13.26% on a QoQ basis from 2420000.0 in Q4 2014.

Scynexis (SCYX) Liabilities from Discontinued Operations (2014 - 2015) Analysis & Trends

Scynexis' Liabilities from Discontinued Operations history runs 2 years deep, the most recent figure standing at 2099000.0 for Q2 2015.

  • Quarterly Liabilities from Discontinued Operations changed N/A year-over-year to 2099000.0 in Q2 2015, while the trailing twelve-month figure through Jun 2015 was 2099000.0 (changed N/A YoY) and the FY2014 annual result came in at 2420000.0, changed N/A from the prior year.
  • Liabilities from Discontinued Operations was 2099000.0 for Q2 2015 at Scynexis, down from 2420000.0 in the prior quarter.
  • Across five years, Liabilities from Discontinued Operations topped out at 2420000.0 in Q4 2014 and bottomed at 2099000.0 in Q2 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Scynexis 21.55 Mn -15.20 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2015 2.10 Mn
Jun 30, 2015 2.10 Mn
Dec 31, 2014 2.42 Mn
Dec 31, 2014 2.42 Mn